Article
Elevated serotonin 1A binding in remitted major depressive disorder: evidence for a trait biological abnormality.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology - 1 Sept 2009
Miller Jeffrey M, Brennan Kathleen G, Ogden Todd R, Oquendo Maria A, Sullivan Gregory M, Mann J John, Parsey Ramin V
Abstract excerpt
Several biological abnormalities in major depressive disorder (MDD) persist during episode remission, including altered serotonin neurotransmission, and may reflect underlying pathophysiology. We previously described elevated brain serotonin 1A (5-HT(1A)) receptor binding in antidepressant-naive (AN) subjects with MDD within a major depressive episode (MDE) compared with that in healthy controls using positron...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
